3D bioprinting stands at the intersection of biology, engineering, and material science, enabling the precise fabrication of tissue constructs that mimic the architecture and function of native human tissues. This paper examines the evolution, techniques, materials, and multifaceted applications of 3D bioprinting in tissue engineering and regenerative medicine. From its foundational principles rooted in additive manufacturing to the development of smart bioinks and complex vascularized constructs, 3D bioprinting offers novel pathways for addressing the shortage of donor organs, personalized medicine, pharmacological testing, and even the development of food alternatives. Despite its promise, the technology faces significant challenges such as limited cell viability, bioink optimization, and unresolved regulatory frameworks. The future of bioprinting depends on interdisciplinary collaboration, innovation in biomaterials, and proactive regulatory engagement to translate laboratory successes into clinical and commercial reality. Keywords: 3D Bioprinting, Tissue Engineering, Regenerative Medicine, Bioink, Scaffold, Smart Biomaterials, Organ Fabrication.
T. Paul Robert (2025) studied this question.